TetraLogic Pharmaceuticals Corp Probability of Future Pink Sheet Price Finishing Over 1.0E-4
| TLOGDelisted Stock | USD 0.0001 0.00 0.00% |
TetraLogic |
TetraLogic Pharmaceuticals Target Price Odds to finish over 1.0E-4
The tendency of TetraLogic Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.0001 | 90 days | 0.0001 | about 78.04 |
Based on a normal probability distribution, the odds of TetraLogic Pharmaceuticals to move above the current price in 90 days from now is about 78.04 (This TetraLogic Pharmaceuticals Corp probability density function shows the probability of TetraLogic Pink Sheet to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days TetraLogic Pharmaceuticals has a beta of 0.64. This usually implies as returns on the market go up, TetraLogic Pharmaceuticals average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding TetraLogic Pharmaceuticals Corp will be expected to be much smaller as well. Additionally TetraLogic Pharmaceuticals Corp has an alpha of 0.3338, implying that it can generate a 0.33 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). TetraLogic Pharmaceuticals Price Density |
| Price |
Predictive Modules for TetraLogic Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as TetraLogic Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.TetraLogic Pharmaceuticals Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. TetraLogic Pharmaceuticals is not an exception. The market had few large corrections towards the TetraLogic Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold TetraLogic Pharmaceuticals Corp, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of TetraLogic Pharmaceuticals within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.33 | |
β | Beta against Dow Jones | 0.64 | |
σ | Overall volatility | 0.0002 | |
Ir | Information ratio | 0.01 |
TetraLogic Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of TetraLogic Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for TetraLogic Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| TetraLogic Pharmaceuticals is not yet fully synchronised with the market data | |
| TetraLogic Pharmaceuticals has some characteristics of a very speculative penny stock | |
| TetraLogic Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| TetraLogic Pharmaceuticals Corp currently holds 28.33 M in liabilities with Debt to Equity (D/E) ratio of 4.17, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. TetraLogic Pharmaceuticals has a current ratio of 0.47, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist TetraLogic Pharmaceuticals until it has trouble settling it off, either with new capital or with free cash flow. So, TetraLogic Pharmaceuticals' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like TetraLogic Pharmaceuticals sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for TetraLogic to invest in growth at high rates of return. When we think about TetraLogic Pharmaceuticals' use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (49.72 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| TetraLogic Pharmaceuticals Corp currently holds about 5.89 M in cash with (34.89 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.24, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
TetraLogic Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of TetraLogic Pink Sheet often depends not only on the future outlook of the current and potential TetraLogic Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. TetraLogic Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 23.7 M | |
| Cash And Short Term Investments | 20.4 M |
TetraLogic Pharmaceuticals Technical Analysis
TetraLogic Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. TetraLogic Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of TetraLogic Pharmaceuticals Corp. In general, you should focus on analyzing TetraLogic Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.
TetraLogic Pharmaceuticals Predictive Forecast Models
TetraLogic Pharmaceuticals' time-series forecasting models is one of many TetraLogic Pharmaceuticals' pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary TetraLogic Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.
Things to note about TetraLogic Pharmaceuticals
Checking the ongoing alerts about TetraLogic Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for TetraLogic Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| TetraLogic Pharmaceuticals is not yet fully synchronised with the market data | |
| TetraLogic Pharmaceuticals has some characteristics of a very speculative penny stock | |
| TetraLogic Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| TetraLogic Pharmaceuticals Corp currently holds 28.33 M in liabilities with Debt to Equity (D/E) ratio of 4.17, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. TetraLogic Pharmaceuticals has a current ratio of 0.47, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist TetraLogic Pharmaceuticals until it has trouble settling it off, either with new capital or with free cash flow. So, TetraLogic Pharmaceuticals' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like TetraLogic Pharmaceuticals sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for TetraLogic to invest in growth at high rates of return. When we think about TetraLogic Pharmaceuticals' use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (49.72 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| TetraLogic Pharmaceuticals Corp currently holds about 5.89 M in cash with (34.89 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.24, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Consideration for investing in TetraLogic Pink Sheet
If you are still planning to invest in TetraLogic Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the TetraLogic Pharmaceuticals' history and understand the potential risks before investing.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |